Skip to main content
Equibles

MORGAN STANLEY

Position in OCGN — Ocugen, Inc.

CIK 895421 NEW YORK, NY
Back to OCGN Full portfolio

Position in OCGN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$574,750
-$652,256 QoQ
Shares Held
375,656
-44.6% QoQ
Ownership
0.111%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 147 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 97% Shared 0% None 3%

Common Shares in OCGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. OCGN ranks #267 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in OCGN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $574,750 375,656
2026-03-31 $1,227,006 677,906
2025-12-31 $625,661 463,454
2025-09-30 $473,616 290,564
2025-06-30 $593,344 611,698
2025-03-31 $595,436 843,397
2024-12-31 $760,418 944,621
2024-09-30 $953,732 961,427
2024-06-30 $972,868 627,659
2024-03-31 $1,015,823 619,405
2023-12-31 $170,295 296,169
2023-09-30 $112,326 280,821
2023-06-30 $189,838 349,614
2023-03-31 $339,301 397,780
2022-12-31 $580,703 446,697
2022-09-30 $753,442 423,284
2022-06-30 $5,711,808 2,516,217
2022-03-31 $6,666,581 2,020,177
2021-12-31 $2,755,573 605,621
2021-09-30 $4,595,793 640,083
2021-06-30 $4,730,231 589,070
2021-03-31 $161,567 23,795
2020-12-31 $118,560 64,787
2020-09-30 $4,946 15,955
2020-06-30 $3,246 14,759